RaySearch postpones the interim report for the first quarter of 2017 because of CEO’s participation in the trade fair PTCOG in Japan

RaySearch Laboratories AB (publ) postpones the interim report for the first quarter of 2017 to 19 May 2017 at 07:45 CET, since the company’s CEO will attend the trade fair PTCOG in Japan on 8-13 May (and thus cannot attend a board meeting in connection with the previously announced date of that report).

RaySearch’s year-end report for 2016 will be released on 17 February 2017 at 07.45 CET as previously announced.

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved radiation therapy of cancer. RaySearch develops and markets the RayStation® treatment planning system to clinics all over the world and distributes the products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare®, which comprises a new product area for RaySearch, and will be launched in 2017. RaySearch’s software is currently used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since November 2003.  

For more information about RaySearch, visit www.raysearchlabs.com.

For further information, please contact:
Johan Löf, CEO              Telephone: +46 8 510 530 00     Email: johan.lof@raysearchlabs.com 
Peter Thysell, CFO         Telephone: +46 70 661 05 59     Email: peter.thysell@raysearchlabs.com

About Us

RaySearch Laboratories AB (publ) has been pushing the limits of advanced cancer treatment since 2000. Using progressive algorithms, RaySearch develops world leading software used by thousands of the most cutting-edge cancer clinics in the world. The algorithms are based upon founder and CEO Johan Löf’s scientific knowledge, acquired during his PhD on radiation treatment of moving tumors at the Karolinska Institute. The treatment planning system RayStation and the OIS RayCare are the result of extensive development during years of research, and today used to improve chances of survival and quality of life for cancer patients. We fight for a world where cancer is conquered.

Subscribe

Documents & Links